Skip to content
Parakho

Choksi Laboratories Ltd

BSE 526546

Q1 FY27, unaudited

Revenue
₹12.06 Cr
Profit after tax
₹0.58 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with BSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations12.06+7.30%46.01
Other income0.02+384.85%0.21
Total income12.08+7.41%46.22
Employee benefit expense4.88+6.33%18.62
Finance costs0.73+21.60%2.82
Depreciation & amortisation1.97+17.57%7.09
Total expenses11.48+8.12%43.78
Profit before tax0.60−4.48%3.19
Tax expense0.02−93.03%1.23
Profit after tax0.58+51.27%1.96
Total comprehensive income0.59+49.40%1.97
Earnings per share
Earnings per share, basic₹0.84₹2.82
Earnings per share, diluted₹0.84₹2.82

Q1 FY27 — unaudited, from the company’s filing with BSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with BSE. Source

FY26 — from the company’s filing with BSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Choksi Laboratories Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 39 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Healthcare Service Provider

Classification as published by BSE.

Companies also in Healthcare Service Provider, in alphabetical order

All 32 companies in Healthcare Service Provider

Page generated from filings held to 05 Oct 2026.